Published :
Tables : 43
Figures : 47
Category : Healthcare
No. of Pages : 221
Report Code : HC-1155
Diagnostic Imaging Market Introduction: Diagnostic Imaging Market to value over US $ 36.4 billion and grow at a CAGR of over 5.2% during the forecast period of 2020 to 2027. With rising consciousness about the benefits of early-stage diagnosis which has resulted in a surge for the demand for diagnostic services.This is regarded as an essential and primary growth inducer for the global medical imaging market. Factors such as rising geriatric population and access to cost-effective medical imaging systems are also making a positive impact on the market. Technological improvements are playing an important role, as it is central to the particular healthcare vertical. Hence, market players are consistently exploring and innovating to develop more efficient medical imaging devices. With the rise in geriatric population, the prevalence of chronic diseases is also on the rise. This is due to the erratic sedentary lifestyle and poor dietary patterns. Cardiovascular and cancerous ailments cause major casualties and are proven to be fatal. Early diagnosis can greatly increase patient survival rate, which is why developing countries are taking initiatives to spread awareness about medical imaging and diagnostics. Demand for diagnostic services is anticipated to grow during the forecast period due to a rise in the number of patients gaining access to medical facilities. Medical imaging will remain a pivotal area of focus for healthcare technology companies.The market is likely to witness new entrants who will explore and fund unique and novel imaging solutions.The emphasis that is being placed on the technical aspects of medical imaging has led to increased processing speed, integrating 3D and 4D imaging technology and automation among others. Such technological enhancements are favoring the adoption of medical imaging in hospitals and diagnostic centers. Globally, North America and Europe will collectively account for major market share in the diagnostic imaging systems market. This can be mainly attributed to the presence of established players, increasing adoption of telemedicine, and the rise in the prevalence of chronic diseases in these regions. The governments across the globe are running awareness programs to educate people regarding early diagnosis of chronic diseases. Such initiatives make patients aware of the early diagnosis among healthcare providers and consumers. Diagnostic imaging has helped doctors to detect diseases in the beginning, thereby improving patient survival rates. Diagnostic imaging systems improve healthcare quality and reduce healthcare costs by shortening recovery time and avoiding unnecessary invasive procedures. Such factors are playing a pivotal role in the growth of the diagnostic imaging systems market. The market is characterized by developments and strategies by main firms. For instance, in 2019, the U.S. Food and Drug Administration (USFDA) approved Siemens Healthineers’ MAGNETOM Lumina 3 Tesla MRI scanner. The system features BioMatrix patient personalization technology, which significantly improves productivity while reducing scan time. Furthermore, in 2018, Carestream Health Inc. received the USFDA 510(k) clearance for its OnSight 3D Extremity System. This imaging system uses cone beam CT technology to capture weight-bearing and other types of extremity exams. These developments fuel the market and advance it globally, thus helping it grow extensively. Major firms in the diagnostic imaging systems market are: GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Agfa-Gevaert N.V., Canon Medical Systems Corporation, Hitachi Ltd., Carestream Health, Inc., Esaote S.p.A, Hologic, Inc., Fujiflim Holdings Corporation, Samsung Electronics Diagnostic Imaging Market Segmentation: By Product X-ray Imaging Systems By Technology X-ray Digital Imaging Systems X-ray Analog Imaging Systems By Portability Stationary Systems Portable Systems Computed Tomography (CT) Scanners Conventional CT Systems Market, by Technology High-slice CT Scanners Mid-slice CT Scanners Low-slice CT Scanners Ultrasound Systems By Technology By Portability Magnetic Resonance Imaging (MRI) Systems By Architecture By Field Strength Nuclear Imaging Systems SPECT Systems Hybrid PET Systems Mammography Systems By Application X-Ray Imaging Systems MRI Systems Ultrasound Systems CT Scanners Nuclear Imaging Systems By End-User Hospitals Diagnostic Imaging Centers Other End Users By Region Europe North America APAC Latin America Rest of the World Competitive Landscape: ● Tier 1 players- established companies in the market with a major market share ● Tier 2 players ● Emerging players which are growing rapidly ● New Entrants FutureWise Takeaways: ● Growth prospects ● SWOT analysis ● Key trends ● Key data points affecting market growth Objectives of the Study: ● To provide an exhaustive analysis on the global diagnostic imaging market by product, by application, by end-user and by region ● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) ● To evaluate and forecast micro-markets and the overall market ● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world ● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions ● Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Diagnostic Imaging Market to value over US $ 36.4 billion and grow at a CAGR of over 5.2% during the forecast period of 2020 to 2027.
With rising consciousness about the benefits of early-stage diagnosis which has resulted in a surge for the demand for diagnostic services.This is regarded as an essential and primary growth inducer for the global medical imaging market. Factors such as rising geriatric population and access to cost-effective medical imaging systems are also making a positive impact on the market. Technological improvements are playing an important role, as it is central to the particular healthcare vertical. Hence, market players are consistently exploring and innovating to develop more efficient medical imaging devices.
With the rise in geriatric population, the prevalence of chronic diseases is also on the rise. This is due to the erratic sedentary lifestyle and poor dietary patterns. Cardiovascular and cancerous ailments cause major casualties and are proven to be fatal. Early diagnosis can greatly increase patient survival rate, which is why developing countries are taking initiatives to spread awareness about medical imaging and diagnostics.
Demand for diagnostic services is anticipated to grow during the forecast period due to a rise in the number of patients gaining access to medical facilities. Medical imaging will remain a pivotal area of focus for healthcare technology companies.The market is likely to witness new entrants who will explore and fund unique and novel imaging solutions.The emphasis that is being placed on the technical aspects of medical imaging has led to increased processing speed, integrating 3D and 4D imaging technology and automation among others. Such technological enhancements are favoring the adoption of medical imaging in hospitals and diagnostic centers.
Globally, North America and Europe will collectively account for major market share in the diagnostic imaging systems market. This can be mainly attributed to the presence of established players, increasing adoption of telemedicine, and the rise in the prevalence of chronic diseases in these regions.
The governments across the globe are running awareness programs to educate people regarding early diagnosis of chronic diseases. Such initiatives make patients aware of the early diagnosis among healthcare providers and consumers. Diagnostic imaging has helped doctors to detect diseases in the beginning, thereby improving patient survival rates. Diagnostic imaging systems improve healthcare quality and reduce healthcare costs by shortening recovery time and avoiding unnecessary invasive procedures. Such factors are playing a pivotal role in the growth of the diagnostic imaging systems market.
The market is characterized by developments and strategies by main firms. For instance, in 2019, the U.S. Food and Drug Administration (USFDA) approved Siemens Healthineers’ MAGNETOM Lumina 3 Tesla MRI scanner. The system features BioMatrix patient personalization technology, which significantly improves productivity while reducing scan time. Furthermore, in 2018, Carestream Health Inc. received the USFDA 510(k) clearance for its OnSight 3D Extremity System. This imaging system uses cone beam CT technology to capture weight-bearing and other types of extremity exams. These developments fuel the market and advance it globally, thus helping it grow extensively.
Major firms in the diagnostic imaging systems market are:
GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Agfa-Gevaert N.V., Canon Medical Systems Corporation, Hitachi Ltd., Carestream Health, Inc., Esaote S.p.A, Hologic, Inc., Fujiflim Holdings Corporation, Samsung Electronics
Diagnostic Imaging Market Segmentation:
By Product
By Application
By End-User
By Region
Competitive Landscape:
● Tier 1 players- established companies in the market with a major market share
● Tier 2 players
● Emerging players which are growing rapidly
● New Entrants FutureWise Takeaways:
● Growth prospects
● SWOT analysis
● Key trends
● Key data points affecting market growth
Objectives of the Study:
● To provide an exhaustive analysis on the global diagnostic imaging market by product, by application, by end-user and by region
● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
● To evaluate and forecast micro-markets and the overall market
● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world
● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
● Profiling of companies to evaluate their market shares, strategies, financials and core competencies
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Diagnostic Imaging Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Diagnostic Imaging Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Diagnostic Imaging Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Diagnostic Imaging Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Diagnostic Imaging Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. MRI Systems 7.1.1. By Architecture 7.1.2. By Field Strength 7.2. Ultrasound Sound Systems 7.2.1. By Technology 7.2.2. By Portability 7.3. Computed Tomography (CT) Scanners 7.3.1 By Type 7.4. Nuclear Imaging Systems 7.4.1. SPECT Systems 7.4.2. Hybrid PET Systems 7.5. X-ray Imaging Systems 7.5.1. By Type 7.5.2. By Portability 7.6. Mammography Systems 8. Global Diagnostic Imaging Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. X-Ray Imaging Systems 8.2. MRI Systems 8.3. Ultrasound Systems 8.4. CT Scanners 8.5. Nuclear Imaging Systems 9. Global Diagnostic Imaging Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Hospital 9.2. Diagnostic Imaging Centers 9.3. Other End Users 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. GE Healthcare 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Siemens Healthineer 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Koninklijke Philips N.V. 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Agfa-Gevaert N.V. 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Canon Medical Systems Corporation 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Hitachi Ltd. 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Carestream Health, Inc. 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Esaote S.p.A 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Hologic, Inc. 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Fujifilm Holdings Corporation 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Samsung Samsung Electronics 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics